Tenaya Therapeutics, Inc. Cash and Cash Equivalents
Tenaya Therapeutics, Inc. (TNYA) had Cash and Cash Equivalents of $78.08 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $78.08M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $80.89M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $100.55M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $56.31M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $78.08M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $80.89M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $100.55M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $56.31M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $62.67M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $53.77M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $4.32M 10-K · filed 2026-03-11 |
| 2024-09-30 | $8.23M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $58.13M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $59.30M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $45.68M 10-K · filed 2025-03-10 |
| 2023-09-30 | $82.15M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $75.56M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $72.54M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $95.27M 10-K · filed 2024-03-18 |
| 2022-09-30 | $34.49M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $31.01M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $25.97M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $38.13M 10-K · filed 2023-03-08 |
| 2021-09-30 | $117.08M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $111.89M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $128.44M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $128.53M 10-K · filed 2022-03-23 |
| 2020-09-30 | $61.34M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $40.34M 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |